Meanwhile, the S&P BSE Sensex was down 58.69 points or 0.3% at 19,487.09.
On BSE, 7,019 shares were traded in the counter as against average daily volume of 9,268 shares in the past one quarter.
The stock hit a high of Rs 838.90 and a low of Rs 822.05 so far during the day. The stock had a record high of Rs 871.80 on 3 June 2013. The stock had hit a 52-week low of Rs 580.80 on 27 June 2012.
The stock had outperformed the market over the past one month till 4 June 2013, surging 21.96% compared with the Sensex's 0.15% fall. The scrip had also outperformed the market in past one quarter, jumping 22.7% as against Sensex's 3.54% gain.
The mid-cap company has equity capital of Rs 42.31 crore. Face value per share is Rs 5.
Shares of Torrent Pharmaceuticals had rallied 16.19% in three trading sessions to settle at Rs 833.15 on Tuesday, 4 June 2013, from a recent low of Rs 717 on 30 May 2013, after the company after market hours on 30 May 2013, reported turnaround Q4 results.
Torrent Pharmaceuticals reported consolidated net profit of Rs 111 crore in Q4 March 2013, as against net loss of Rs 2 crore in Q4 March 2012. Net sales rose 22.8% to Rs 803 crore in Q4 March 2013 over Q4 March 2012.
Torrent Pharmaceuticals' board of directors at a meeting held on 30 May 2013, recommended issue of bonus shares in the ratio of 1:1. The board also recommended a dividend of Rs 7 per share for FY 2013 in addition to a special dividend of Rs 10 per share commemorating four decades of the company's business operations.
Torrent Pharmaceuticals is the flagship company of the Torrent Group. The pharmaceutical firm has focus on the therapeutics areas of diabetology, cardiovascular, central nervous system, gastro-intestinal, anti-infective, pain management and gynecology.
Powered by Capital Market - Live News
